ForthcomingGrantEligibility not yet screened

‘Proof of market’ to improve valorisation and commercialisation of Horizon generated R&I results (IA)

European Commission · Horizon Europe Framework Programme (HORIZON)

Posted 22 Sept 2026 · About 4 months left

Summary

Expected Outcome:

The commercial potential of Horizon research results is explored;

Results of Horizon projects are valorised, by ensuring a pathway to commercialisation; and

Startups and SMEs become involved in valorisation.

Scope:

The EU must do better in translating the knowledge generated by the Framework Programme into innovations with economic and societal value.

The objective of this action is to provide financial support (‘Proof of market’) to small consortia (i.e. spin-offs, startups, SMEs) to explore the exploitation potential, in the EU, of achieved results from ongoing or completed projects funded under Cluster 4 ‘Digital, Industry and Space’ or its predecessor activities under the Leadership in enabling and industrial technologies (LEIT)[1] part of Horizon 2020.

The consortia do not necessarily have to be made of former or current beneficiaries but should own or have access to the knowledge assets of projects, including intellectual property, where relevant.

Proposals should envisage valorisation activities, such as:

demonstrating a technology (e.g. testing);

defining a commercialisation process;

undertaking: a market and competitiveness analysis;

a technology…

Excerpt from the donor's page. The full text, annexes and forms are on the original call.

Eligibility and conditions

Show the eligibility text from the source

">General conditions

1. Admissibility Conditions: Proposal page limit and layout

described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.

Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.

2. Eligible Countries

described in Annex B of the Work Programme General Annexes.

A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.

3. Other Eligible Conditions

In line with the “restriction on control in innovation actions in critical technology areas” delineated in General Annex B of the General Annexes, entities established in an eligible country but which are directly or indirectly controlled by China or by a legal entity established in China are not eligible to participate in the action.

described in Annex B of the Work Programme General Annexes.

4. Financial and operational capacity and exclusion

described in Annex C of the Work Programme General Annexes.

5a. Evaluation and award: Award criteria, scoring and thresholds

are described in Annex D of the Work Programme General Annexes.

5b. Evaluation and award: Submission and evaluation processes

are described in Annex F of the Work Programme General Annexes and the Online Manual.

5c. Evaluation and award: Indicative timeline for evaluation and grant agreement

described in Annex F of the Work Programme General Annexes.

6. Legal and financial set-up of the grants

The granting authority may, up to 4 years after the end of the action, object to a transfer of ownership or to the exclusive licensing of results, as set out in the specific provision of Annex 5.

described in Annex G of the Work Programme General Annexes.

Specific conditions

described in the [specific topic of the Work Programme]

Application and evaluation forms and model grant agreement (MGA):

Application form templates — the application form specific to this call is available in the Submission System

Standard application form (HE RIA, IA)

Evaluation form templates — will be used with the necessary adaptations

Standard evaluation form (HE RIA, IA)

Guidance

HE Programme Guide

Model Grant Agreements (MGA)

HE MGA

Operating Grants MGA

Framework Partnership Agreement FPA

Call-specific instructions

Information on financial support to third parties (HE)

Information on clinical studies (HE)

Additional documents:

HE Main Work Programme 2026-2027 – 1. General Introduction

HE Main Work Programme 2026-2027 – 7. Digital, Industry and Space

HE Main Work Programme 2026-2027 – 14. Horizontal Activities

HE Main Work Programme 2026-2027 – 15. General Annexes

HE Programme Guide

HE Framework Programme 2021/695

HE Specific Programme Decision 2021/764

EU Financial Regulation 2024/2509

Decision authorising the use of lump sum contributions under the Horizon Europe Programme

Rules for Legal Entity Validation, LEAR Appointment and Financial Capacity Assessment

EU Grants AGA — Annotated Model Grant Agreement

Funding & Tenders Portal Online Manual

Funding & Tenders Portal Terms and Conditions

Funding & Tenders Portal Privacy Statement

Themes